-
1
-
-
0025889029
-
The incidence of narcotic-induced emesis
-
Campora E, Merlini L, Pace M, Bruzzone M, Luzanni M, Gottlieb A, Rosso R: The incidence of narcotic-induced emesis. J Pain Sympt Manag 1991; 6:428-30
-
(1991)
J Pain Sympt Manag
, vol.6
, pp. 428-430
-
-
Campora, E.1
Merlini, L.2
Pace, M.3
Bruzzone, M.4
Luzanni, M.5
Gottlieb, A.6
Rosso, R.7
-
2
-
-
0032837703
-
Opioid-induced emesis among hospitalized nonsurgical patients: Effect on pain and quality of life
-
Aparasu R, McCoy RA, Weber C, Mair D, Parasuraman TV: Opioid-induced emesis among hospitalized nonsurgical patients: Effect on pain and quality of life. J Pain Sympt Manag 1999; 18:280-8
-
(1999)
J Pain Sympt Manag
, vol.18
, pp. 280-288
-
-
Aparasu, R.1
McCoy, R.A.2
Weber, C.3
Mair, D.4
Parasuraman, T.V.5
-
3
-
-
0026681384
-
The neuropharmacology of loperamide-induced emesis in the ferret: The role of the area postrema, vagus, opiate and 5-HT3 receptors
-
Bhandari P, Bingham S, Andrews PL: The neuropharmacology of loperamide-induced emesis in the ferret: The role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacol 1992; 31:735-42
-
(1992)
Neuropharmacol
, vol.31
, pp. 735-742
-
-
Bhandari, P.1
Bingham, S.2
Andrews, P.L.3
-
4
-
-
0027220295
-
The effects of different antiemetic agents on morphine-induced emesis in ferrets
-
Wynn RL, Essien E, Thut PD: The effects of different antiemetic agents on morphine-induced emesis in ferrets. Eur J Pharmacol 1993; 241:47-54
-
(1993)
Eur J Pharmacol
, vol.241
, pp. 47-54
-
-
Wynn, R.L.1
Essien, E.2
Thut, P.D.3
-
5
-
-
0032998173
-
Insufficient effectiveness of 5 hydroxytryptamine antagonists due to oral morphine administration in patients with cisplatin-induced emesis
-
Shoji A, Toda M, Suzuki K, Takahashi H, Takahashi K, Yoshiike Y, Ogura T, Watanuki Y, Nishiyama H, Odagiri S: Insufficient effectiveness of 5 hydroxytryptamine antagonists due to oral morphine administration in patients with cisplatin-induced emesis. J Clin Oncol 1999; 17:1926-30
-
(1999)
J Clin Oncol
, vol.17
, pp. 1926-1930
-
-
Shoji, A.1
Toda, M.2
Suzuki, K.3
Takahashi, H.4
Takahashi, K.5
Yoshiike, Y.6
Ogura, T.7
Watanuki, Y.8
Nishiyama, H.9
Odagiri, S.10
-
6
-
-
0032807846
-
Intravenous ondansetron for the control of opioid-induced nausea and vomiting
-
Sussman G, Shurman J, Creed MR, Larsen LM, Ferrer-Brechner T, Noll D, Allegra J, Montgomery R, Schreck D, Grafstein E, Ramalanjaona G, Patel V, Ducharme J, Ortenwall P, Foster E, Ames M: Intravenous ondansetron for the control of opioid-induced nausea and vomiting. Clin Ther 1999; 21:1216-27
-
(1999)
Clin Ther
, vol.21
, pp. 1216-1227
-
-
Sussman, G.1
Shurman, J.2
Creed, M.R.3
Larsen, L.M.4
Ferrer-Brechner, T.5
Noll, D.6
Allegra, J.7
Montgomery, R.8
Schreck, D.9
Grafstein, E.10
Ramalanjaona, G.11
Patel, V.12
Ducharme, J.13
Ortenwall, P.14
Foster, E.15
Ames, M.16
-
7
-
-
0021688369
-
Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer patients with chemotherapy-induced emesis
-
Stambaugh JE, Mc Adams J, Vreeland F: Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer patients with chemotherapy-induced emesis. J Clin Pharmacol 1984; 24:480-5
-
(1984)
J Clin Pharmacol
, vol.24
, pp. 480-485
-
-
Stambaugh, J.E.1
Mc Adams, J.2
Vreeland, F.3
-
8
-
-
0033884835
-
Cannabinoids modulate pain by multiple mechanisms of action
-
Richardson JD: Cannabinoids modulate pain by multiple mechanisms of action. J Pain 2000; 1:2-14
-
(2000)
J Pain
, vol.1
, pp. 2-14
-
-
Richardson, J.D.1
-
10
-
-
0018779303
-
Suppression of cancer chemotherapy induced vomiting in the cat by nabilone, a synthetic cannabinoid
-
London SW, McCarthy LE, Borison HL: Suppression of cancer chemotherapy induced vomiting in the cat by nabilone, a synthetic cannabinoid. Proc Soc Exp Biol Med 1979; 160:437-40
-
(1979)
Proc Soc Exp Biol Med
, vol.160
, pp. 437-440
-
-
London, S.W.1
McCarthy, L.E.2
Borison, H.L.3
-
11
-
-
0024359059
-
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid
-
Feigenbaum JJ, Richmond SA, Weissman Y, Mechoulam R: Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid. Eur J Pharmacol 1989; 169:159-65
-
(1989)
Eur J Pharmacol
, vol.169
, pp. 159-165
-
-
Feigenbaum, J.J.1
Richmond, S.A.2
Weissman, Y.3
Mechoulam, R.4
-
12
-
-
0032951515
-
Cannabimimetic activity in rats and pigeons of HU210, a potent antiemetic drug
-
Ferrari F, Ottani A, Giuliani D: Cannabimimetic activity in rats and pigeons of HU210, a potent antiemetic drug. Pharmacol Biochem Behav 1999; 62:75-80
-
(1999)
Pharmacol Biochem Behav
, vol.62
, pp. 75-80
-
-
Ferrari, F.1
Ottani, A.2
Giuliani, D.3
-
13
-
-
0020360779
-
Randomized clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting
-
Lucraft HH, Palmer MK: Randomized clinical trial of levonantradol and chlorpromazine in the prevention of radiotherapy-induced vomiting. Clin Radiol 1982; 33:621-2
-
(1982)
Clin Radiol
, vol.33
, pp. 621-622
-
-
Lucraft, H.H.1
Palmer, M.K.2
-
14
-
-
0024477741
-
5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret
-
Higgins GA, Kirkpatrick GJ, Bunce KT, Jones BJ, Tyers MB: 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 1989; 97:247-55
-
(1989)
Br J Pharmacol
, vol.97
, pp. 247-255
-
-
Higgins, G.A.1
Kirkpatrick, G.J.2
Bunce, K.T.3
Jones, B.J.4
Tyers, M.B.5
-
15
-
-
0025230892
-
The abdominal visceral innervation and the antiemetic reflex: Pathways, pharmacology and plasticity
-
Andrews PLR, Davis CL, Bingham S, Davidson HIM, Hawthorn J, Maskell L: The abdominal visceral innervation and the antiemetic reflex: pathways, pharmacology and plasticity. Can J Physiol Pharmacol 1990; 68:325-45
-
(1990)
Can J Physiol Pharmacol
, vol.68
, pp. 325-345
-
-
Andrews, P.L.R.1
Davis, C.L.2
Bingham, S.3
Davidson, H.I.M.4
Hawthorn, J.5
Maskell, L.6
-
16
-
-
0027419943
-
Global experience with ondansetron and future potential
-
Butcher ME: Global experience with ondansetron and future potential. Oncology 1993; 50:191-7
-
(1993)
Oncology
, vol.50
, pp. 191-197
-
-
Butcher, M.E.1
-
17
-
-
0023522553
-
Antiemetic properties of the 5-HT3 receptor antagonist GR38032F
-
Stables R, Andrews PLR, Bailey HE, Costall B, Gunning SJ, Hawthorn J, Naylor RJ, Tyers MB: Antiemetic properties of the 5-HT3 receptor antagonist GR38032F. Cancer Treat Rep 1987; 14:333-6
-
(1987)
Cancer Treat Rep
, vol.14
, pp. 333-336
-
-
Stables, R.1
Andrews, P.L.R.2
Bailey, H.E.3
Costall, B.4
Gunning, S.J.5
Hawthorn, J.6
Naylor, R.J.7
Tyers, M.B.8
-
18
-
-
0025221823
-
Vagal-induced vomiting is not supressed by specific 5-HT3 receptor antagonists
-
Milano S, Grelot L, Chen Z, Bianchi AL: Vagal-induced vomiting is not supressed by specific 5-HT3 receptor antagonists. J Auton Nerv Syst 1990; 31:109-18
-
(1990)
J Auton Nerv Syst
, vol.31
, pp. 109-118
-
-
Milano, S.1
Grelot, L.2
Chen, Z.3
Bianchi, A.L.4
-
21
-
-
0020699588
-
On the receiving end: Patient perceptions of the side effects of cancer chemotherapy
-
Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MHN: On the receiving end: Patient perceptions of the side effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983; 19:203-8
-
(1983)
Eur J Cancer Clin Oncol
, vol.19
, pp. 203-208
-
-
Coates, A.1
Abraham, S.2
Kaye, S.B.3
Sowerbutts, T.4
Frewin, C.5
Fox, R.M.6
Tattersall, M.H.N.7
-
22
-
-
0027214205
-
Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs
-
Foss JF, Bass AS, Goldberg LI: Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. J Clin Pharmacol 1993; 33:747-51
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 747-751
-
-
Foss, J.F.1
Bass, A.S.2
Goldberg, L.I.3
-
23
-
-
0017717415
-
Naloxone antagonizes narcotic self blockade of emesis in the cat
-
Costello DJ, Borison HL: Naloxone antagonizes narcotic self blockade of emesis in the cat. J Pharmacol Exp Ther 1997; 203:222-30
-
(1997)
J Pharmacol Exp Ther
, vol.203
, pp. 222-230
-
-
Costello, D.J.1
Borison, H.L.2
-
24
-
-
0031826621
-
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine
-
Foss JF, Yuan CS, Roizen MF, Goldberg LI: Prevention of apomorphine-or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine. Cancer Chemother Pharmacol 1998; 42:287-91
-
(1998)
Cancer Chemother Pharmacol
, vol.42
, pp. 287-291
-
-
Foss, J.F.1
Yuan, C.S.2
Roizen, M.F.3
Goldberg, L.I.4
-
25
-
-
0024204359
-
Regulation of gastro-intestinal function by multiple opioid receptors
-
Burks TF, Fox DA, Hirning LD, Shook JE, Porreca F: Regulation of gastro-intestinal function by multiple opioid receptors. Life Sci 1988; 43:2177-81
-
(1988)
Life Sci
, vol.43
, pp. 2177-2181
-
-
Burks, T.F.1
Fox, D.A.2
Hirning, L.D.3
Shook, J.E.4
Porreca, F.5
-
26
-
-
0029788231
-
Mechanism of chemotherapy/radiotherapy-induced emesis in animal models
-
Naylor RJ, Rudd JA: Mechanism of chemotherapy/radiotherapy-induced emesis in animal models. Oncology 1996; 53(suppl 1):8-17
-
(1996)
Oncology
, vol.53
, Issue.1 SUPPL.
, pp. 8-17
-
-
Naylor, R.J.1
Rudd, J.A.2
-
27
-
-
4143108422
-
Binding of the non-classical cannabinoid CP55,940 and the diarylpyrazole AM251 to rodent brain cannabinoid receptors
-
Galley SJ, Lan R, Pyatt B, Gifford AN, Volkow ND, Makriyannis A: Binding of the non-classical cannabinoid CP55,940 and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci 1997; 61:PL191-7
-
(1997)
Life Sci
, vol.61
-
-
Galley, S.J.1
Lan, R.2
Pyatt, B.3
Gifford, A.N.4
Volkow, N.D.5
Makriyannis, A.6
-
28
-
-
0029043608
-
AM630, a competitive cannabinoid receptor antagonist
-
Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A, AM630, a competitive cannabinoid receptor antagonist. Life Sci 1995; 56:1949-55
-
(1995)
Life Sci
, vol.56
, pp. 1949-1955
-
-
Pertwee, R.1
Griffin, G.2
Fernando, S.3
Li, X.4
Hill, A.5
Makriyannis, A.6
-
29
-
-
0032588414
-
Evaluation of the cannabinoid CB2 receptor selective antagonist, SR144528: Further evidence of cannabinoid CB2 receptor absence in the rat central nervous system
-
Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME: Evaluation of the cannabinoid CB2 receptor selective antagonist, SR144528: Further evidence of cannabinoid CB2 receptor absence in the rat central nervous system. Eur J Pharmacol 1999; 377:117-25
-
(1999)
Eur J Pharmacol
, vol.377
, pp. 117-125
-
-
Griffin, G.1
Wray, E.J.2
Tao, Q.3
McAllister, S.D.4
Rorrer, W.K.5
Aung, M.M.6
Martin, B.R.7
Abood, M.E.8
-
30
-
-
0031929438
-
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
-
Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM: Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1988; 83:393-411
-
(1988)
Neuroscience
, vol.83
, pp. 393-411
-
-
Tsou, K.1
Brown, S.2
Sanudo-Pena, M.C.3
Mackie, K.4
Walker, J.M.5
-
31
-
-
0032982010
-
Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630
-
Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG: Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630. Br J Pharmacol 1999; 126: 665-72
-
(1999)
Br J Pharmacol
, vol.126
, pp. 665-672
-
-
Ross, R.A.1
Brockie, H.C.2
Stevenson, L.A.3
Murphy, V.L.4
Templeton, F.5
Makriyannis, A.6
Pertwee, R.G.7
-
32
-
-
0027989509
-
Profiles of emetic action of cisplatin in the ferret: A potential model of acute and delayed emesis
-
Rudd JA, Jordan CC, Naylor RJ: Profiles of emetic action of cisplatin in the ferret: A potential model of acute and delayed emesis. Eur J Pharmacol 1994; 262:R1-2
-
(1994)
Eur J Pharmacol
, vol.262
-
-
Rudd, J.A.1
Jordan, C.C.2
Naylor, R.J.3
-
33
-
-
0000054748
-
Does retching have a function? An experimental study in the ferret
-
Andrews PLR, Bhandari P, Garland S, Bingham S, Davis CJ, Hawthorn J, Davidson HIM, Roylance R, Lane S: Does retching have a function? An experimental study in the ferret. Pharmacodyn Ther 1990; 9:135-52
-
(1990)
Pharmacodyn Ther
, vol.9
, pp. 135-152
-
-
Andrews, P.L.R.1
Bhandari, P.2
Garland, S.3
Bingham, S.4
Davis, C.J.5
Hawthorn, J.6
Davidson, H.I.M.7
Roylance, R.8
Lane, S.9
-
34
-
-
0024370916
-
Psychoactive cannabinoids reduce gastrointestinal propulsion and mobility in rodents
-
Shook JE, Burks TF: Psychoactive cannabinoids reduce gastrointestinal propulsion and mobility in rodents. J Pharmacol Exp Ther 1989; 249:544-51
-
(1989)
J Pharmacol Exp Ther
, vol.249
, pp. 544-551
-
-
Shook, J.E.1
Burks, T.F.2
-
35
-
-
0032443374
-
Analgesic respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: Antagonist effects of SR 141716A
-
Vivian IA, Kishioka S, Butelman ER, Broadbear J, Lee KO, Woods JH: Analgesic respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: Antagonist effects of SR 141716A. J Pharmacol Exp Ther 1998; 286:697-703
-
(1998)
J Pharmacol Exp Ther
, vol.286
, pp. 697-703
-
-
Vivian, I.A.1
Kishioka, S.2
Butelman, E.R.3
Broadbear, J.4
Lee, K.O.5
Woods, J.H.6
-
36
-
-
1642602474
-
Behavioral effects of cannabinoid agents in animals
-
Chaperon F, Thiebot M-H: Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 1999; 13:243-81
-
(1999)
Crit Rev Neurobiol
, vol.13
, pp. 243-281
-
-
Chaperon, F.1
Thiebot, M.-H.2
|